SURE-NAC
DEAD

Serial Number

86227226

Owner

Tiara Pharmaceuticals

Filing Date

Mar 20, 2014

Add to watchlist:

No watchlists yet
View on USPTO

SURE-NAC Trademark

Serial Number: 86227226

SURE-NAC is a trademark filed by Tiara Pharmaceuticals on March 20, 2014. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Tiara Pharmaceuticals (2 trademarks)

4546 B10 El camino Real #304
Los Altos, CA 94022

Entity Type: 03

Trademark Details

Filing Date

March 20, 2014

Registration Date

Not Registered

Published for Opposition

August 5, 2014

Goods & Services

Anti-diabetic pharmaceuticals; Antibacterial pharmaceuticals; Cardiovascular pharmaceuticals; Cellulose esters for pharmaceutical purposes; Dermatological pharmaceutical products; Digestives for pharmaceutical purposes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical agents for treating physically caused lesions; Pharmaceutical preparation for skin care; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; the foregoing goods containing N-acetylcysteine

Active chemical ingredients for use in the manufacture of pharmaceuticals for treating inflammatory conditions; Bio-metallic compounds for use in the manufacture of pharmaceutical preparations; Chemical additives for use in the manufacture of anti-inflammatory agent; Emollient used as an ingredient in the manufacture of cosmetics, toiletries, and pharmaceuticals; Excipients for use in the manufacture of anti-inflammatory; Glycerine for use in the manufacture of pharmaceuticals; Glycerol for use in the manufacture of medicine; Phenothiazine for use as a pharmaceutical intermediate; Polymers and polymeric additives for use in the manufacture of pharmaceutical preparations, medical devices, plastics, cosmetics, personal care products, coatings, adhesives, and lubricants; Polymers and polymeric additives for use in the manufacture of pharmaceutical preparations, plastics, cosmetics, personal care products, coatings, adhesives, and lubricants; the foregoing goods containing N-acetylcysteine

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Sep 8, 2015 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 7, 2015 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 3, 2015 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Dec 19, 2014 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Aug 21, 2014 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 5, 2014 NPUB
PUBLISHED FOR OPPOSITION
Aug 5, 2014 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 16, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 30, 2014 PREV
ASSIGNED TO LIE
Jun 30, 2014 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 12, 2014 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 12, 2014 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 12, 2014 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 12, 2014 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 12, 2014 CNEA
ASSIGNED TO EXAMINER
Jun 10, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 3, 2014 NWOS
NEW APPLICATION ENTERED
Mar 24, 2014 NWAP